His primary areas of investigation include Asthma, Internal medicine, Anesthesia, Immunology and Bronchodilator. His Asthma research incorporates elements of Respiratory disease, Intensive care, Placebo, Corticosteroid and Physical therapy. His biological study spans a wide range of topics, including Gastroenterology and Endocrinology.
His studies in Anesthesia integrate themes in fields like Crossover study, Refractory, Randomized controlled trial, Methacholine and Spirometry. Elliot Israel has included themes like Receptor, Prostaglandin D2 and Bronchoalveolar lavage in his Immunology study. His Bronchodilator study incorporates themes from Morning, Inhalation and Salbutamol.
Elliot Israel mostly deals with Asthma, Internal medicine, Immunology, Anesthesia and Physical therapy. His studies deal with areas such as Respiratory disease, Randomized controlled trial, Intensive care medicine, Corticosteroid and Cohort as well as Asthma. His Cohort study integrates concerns from other disciplines, such as Odds ratio and Pediatrics.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Placebo and Endocrinology. His research on Immunology often connects related topics like Bronchoalveolar lavage. His research integrates issues of Crossover study and Bronchodilator in his study of Anesthesia.
His primary areas of study are Asthma, Internal medicine, Immunology, Severe asthma and Corticosteroid. His work deals with themes such as Inflammation, Exacerbation, Intensive care medicine, Pediatrics and Cohort, which intersect with Asthma. He interconnects Gastroenterology and Airway in the investigation of issues within Internal medicine.
The concepts of his Immunology study are interwoven with issues in Rhinovirus, Expression quantitative trait loci and Gene expression. The Severe asthma study combines topics in areas such as Eosinophil and Lung function. His Corticosteroid research includes themes of Quality of life and Triamcinolone acetonide.
His main research concerns Asthma, Internal medicine, Immunology, Severe asthma and Inflammation. His Asthma research includes elements of Exacerbation, Interleukin 6, Corticosteroid, Lung function and Cohort. His Internal medicine study frequently links to related topics such as Gastroenterology.
His work carried out in the field of Immunology brings together such families of science as Rhinovirus and Gene expression. In Severe asthma, he works on issues like Eosinophilia, which are connected to Phenotype, Asthma therapy, Pulmonary vasculature and Disease severity. He has researched Inflammation in several fields, including Immunoglobulin E, Bronchoalveolar lavage and Sensitization.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Wendy C. Moore;Deborah A. Meyers;Sally E. Wenzel;W. Gerald Teague.
american thoracic society international conference (2010)
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Jeffrey M. Drazen;Elliot Israel;Paul M. O'Byrne.
The New England Journal of Medicine (1999)
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Wendy C. Moore;Eugene R. Bleecker;Douglas Curran-Everett;Serpil C. Erzurum.
The Journal of Allergy and Clinical Immunology (2007)
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: A multicenter, randomized, double-blind, sham-controlled clinical trial
Mario Castro;Adalberto S. Rubin;Michel Laviolette;Jussara Fiterman.
American Journal of Respiratory and Critical Care Medicine (2010)
The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma
Elliot Israel;Jeffrey M. Drazen;Stephen B. Liggett;Homer A. Boushey.
American Journal of Respiratory and Critical Care Medicine (2000)
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.
Jeffrey M. Drazen;Chandri N. Yandava;Louise Dubé;Natalie Szczerback.
Nature Genetics (1999)
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Elliot Israel;Vernon M. Chinchilli;Jean G. Ford;Homer A. Boushey.
The Lancet (2004)
Significant variability in response to inhaled corticosteroids for persistent asthma
Stanley J. Szefler;Richard J. Martin;Tonya Sharp King;Homer A. Boushey.
The Journal of Allergy and Clinical Immunology (2002)
Tiotropium bromide step-up therapy for adults with uncontrolled asthma
Stephen P. Peters;Susan J. Kunselman;Nikolina Icitovic;Wendy C. Moore.
The New England Journal of Medicine (2010)
Daily versus As-Needed Corticosteroids for Mild Persistent Asthma
Homer A. Boushey;Christine A. Sorkness;Tonya S. King;Sean D. Sullivan.
The New England Journal of Medicine (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: